Skip to main content
. 2019 Aug 31;10(1):10.24926/iip.v10i1.1611. doi: 10.24926/iip.v10i1.1611

Table 5. Existing collaborative practice agreements (CPAs) (n=40).

Collaborative practice agreements (CPA) exist for the following conditions: N (%)
Anticoagulation 12 (30%)
Asthma 18 (45%)
COPD 16 (40%)
Depression 12 (30%)
Diabetes 27 (67.5%)
Dyslipidemia 23 (57.5%)
Flu/antiviral 3 (7.5%)
GERD 11 (27.5%)
Hypertension 29 (72.5%)
Hypothyroidism 19 (47.5%)
Pain 15 (37.5%)
Tobacco cessation 26 (65%)
Currently no CPAs are in place 6 (15%)